• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
CommentaryRoe v. Wade

With Roe v. Wade out, we need male contraception more than ever

By
Akash Bakshi
Akash Bakshi
Down Arrow Button Icon
By
Akash Bakshi
Akash Bakshi
Down Arrow Button Icon
July 29, 2022, 6:15 AM ET
Hormonal contraceptive methods for women come with side effects such as mood changes, depression, an increased risk of breast and cervical cancer, and blood clots. But when it comes to men, it is widely assumed side effects would be unacceptable.
Hormonal contraceptive methods for women come with side effects such as mood changes, depression, an increased risk of breast and cervical cancer, and blood clots. But when it comes to men, it is widely assumed side effects would be unacceptable.Getty Images

Roe v. Wade has been overturned, resulting in reduced access to safe and effective abortions. It’s a devastating moment for the health and well-being of American women and individuals who can become pregnant.

We should consider why women need abortions in the first place. For many (but not all–some women require abortions for medical reasons), it’s unintended pregnancy. For every two pregnant women in America, one of their pregnancies is unintended. About 40% of those women choose to have an abortion, which is now outlawed in as many as 28 states in America. 

But unplanned isn’t a synonym for unprotected. As many as 50% of couples observed in a study by the Guttmacher Institute were actively using a contraceptive when they became pregnant. It won’t be a surprise to learn that condoms are behind many well-intentioned yet failed efforts to prevent pregnancy. The pill, too, can fail: 12% of women who seek an abortion were on the pill. 

Of course, the protections previously granted by Roe must be codified into law. But we also need better contraceptives. We always have. We need to empower people to prevent unwanted pregnancy and the need for abortion. We can also increase access to highly effective contraceptives and bring men into the conversation. After all, women don’t get pregnant alone.  

Efficacy aside, nearly every woman who is on a hormonal contraceptive weighs side effects that include mood changes, depression, an increased risk of breast and cervical cancer, and blood clots.

Male birth control doesn’t exist today beyond the technologies developed in the 1800s: condoms, which come with high failure rates, or vasectomies, which aren’t yet reliably reversible. But if it did, we could decrease unintended pregnancies and, in today’s America, unsafe abortions. 

We need men to claim their full equal responsibility for reproductive health–and it’s not an unrealistic notion. Nearly 75% of women and about 72% of men believe both sexual partners should be equally responsible for birth control. There is a massive untapped market for novel male contraceptives that are highly effective, reversible, and convenient to use. There is also a glaring gap in interest, research, and funding in the field of male reproduction. Biologically, it’s challenging: successful contraception requires us to stop millions of sperm from reaching an egg, and it’s difficult to target human sperm cells.

To suggest that men aren’t looking beyond the condom simply doesn’t reflect the current mood: A recent survey showed that 17 million American men are seeking better contraceptive methods for themselves. 

This wasn’t always the case, of course: It’s widely believed that demand for male contraceptive methods didn’t exist until after paternity tests were developed, putting men on the hook for raising their own offspring.

Regardless, it’s a whole new era for heterosexual women and their relationship with male partners. The #MeToo movement and the 2017 Women’s March on Washington come to mind as flashpoints for modern feminism which aim to hold the country’s most powerful men to account and include a focus on sexual empowerment centered on women’s pleasure. 

Still, many assumed men would be turned off by the possibility of side effects, which suggests a gross double standard in which side effects are acceptable for women but unacceptable for men–a notion that also does not align with the values that younger generations are striving for. 

Let’s empower men to step up during a moment when women’s access to safe and effective abortions is now in grave danger. 

An affordable, reversible contraceptive for men is possible. Private companies are commercializing therapeutics and devices that non-hormonally bring sperm counts below fertile limits in men, essentially offering the benefits of a highly effective contraceptive to men. Other institutions are trialing hormonal methods with tentatively promising efficacy. 

These developments give me hope that someday we can decrease the hormonal burden we put on women in the name of preventing pregnancy. It’s a burden that has compelled so many women to share their stories with me about the effects of birth control on their lives. It’s personal and real. The development of male contraceptives covered by insurance and widely adopted by men can radically change that.

Attacks on reproductive autonomy and a lack of male birth control have put women in devastating positions. But if we’re to decrease the need for abortion, we’ll need men to take on a fair share of responsibility in preventing unwanted pregnancies–and a whole lot of research, funding, and awareness to get us there.

Akash Bakshi is the CEO and co-founder of YourChoice Therapeutics, a company that is developing a birth control pill for men. Akash holds degrees in Biochemistry and Cell Biology from UC San Diego and University of Queensland.

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not reflect the opinions and beliefs of Fortune.

More must-read commentary published by Fortune:

  • COVID got me. Will it come for you?
  • Why remote work will win this fall
  • A list of companies supporting abortion rights after the Roe v. Wade ruling shows which firms are stepping up, and why
  • Career hoarding is on the rise—but it comes at a cost
  • Venture capital is hard–and it’s supposed to be

Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Author
By Akash Bakshi
See full bioRight Arrow Button Icon

Latest in Commentary

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Commentary

hawkinson
CommentaryInfrastructure
Your essential services are one surprise failure away from disruption. Consider how physical AI could tackle the crisis
By Alex HawkinsonFebruary 14, 2026
5 hours ago
sunaina
Commentaryprivate equity
Private equity’s playbook to shake off the zombies: meet the continuation vehicle
By Sunaina Sinha HaldeaFebruary 14, 2026
5 hours ago
school
CommentaryEducation
Our K-12 school system is sending us a message: AI tools are for the rich kids
By Jerel EzellFebruary 14, 2026
6 hours ago
ikea
CommentaryLeadership
How leaders are protecting culture while AI rewrites how work gets done
By Keith Ferrazzi and Ulrika BiesertFebruary 14, 2026
9 hours ago
dog
CommentaryAnimals
You love your dog too much. Blame the broken American Dream and loss of purpose since the pandemic
By Margret Grebowicz and The ConversationFebruary 13, 2026
1 day ago
julio
CommentaryLeadership
Why choosing not to hire was the solution for my startup — we raised over $100 million and tripled revenue with the same people
By Julio MartínezFebruary 13, 2026
1 day ago

Most Popular

placeholder alt text
AI
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI
By Jake AngeloFebruary 13, 2026
1 day ago
placeholder alt text
Economy
Some folks on Wall Street think yesterday’s U.S. jobs number is ‘implausible’ and thus due for a downward correction
By Jim EdwardsFebruary 12, 2026
2 days ago
placeholder alt text
North America
‘I gave another girl to Kimbal’: Inside Jeffrey Epstein’s honey-trap plan targeting Elon Musk through his brother
By Eva Roytburg and Jessica MathewsFebruary 13, 2026
1 day ago
placeholder alt text
Success
Actress Jennifer Garner just took her $724 million organic food empire public. She started her career making just $150 weekly as a ‘broke’ understudy
By Emma BurleighFebruary 13, 2026
1 day ago
placeholder alt text
Success
MacKenzie Scott says her college roommate loaned her $1,000 so she wouldn't have to drop out—and is now inspiring her to give away billions
By Sydney LakeFebruary 14, 2026
6 hours ago
placeholder alt text
Commentary
Something big is happening in AI — and most people will be blindsided
By Matt ShumerFebruary 11, 2026
3 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.